Trial Outcomes & Findings for A Randomized Controlled Trial of Ambient Artificial Intelligence Scribe Technologies (NCT NCT06792890)
NCT ID: NCT06792890
Last Updated: 2026-04-24
Results Overview
The primary outcome measure is the change in provider mean time in notes per note in the second month of the trial from the providers baseline mean time in notes per note for the six months prior to enrollment. This change will be computed on the natural log scale. No patient level information will be collected for this outcome measure.
COMPLETED
NA
238 participants
Study month 2
2026-04-24
Participant Flow
Of 331 providers expressing interest, 93 were excluded due to ineligibility, declining participation, incomplete surveys, or decision-making roles. The remaining 238 were randomized to the arms.
Participant milestones
| Measure |
Nabla, Vendor of Virtual AI Scribe Technology
Participants in this arm will utilize AI scribe tools from Nabla and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The Nabla AI scribe tool is transcriptional and does not provide clinical decision support.
Use Nabla AI Scribe tool provided: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio.
|
Vendor B of Virtual AI Scribe Technology
Participants in this arm will utilize AI scribe tools from Vendor B and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The AI scribe tool is transcriptional and does not provide clinical decision support.
Use AI Scribe tool provided by Vendor B: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
|
No Scribe
Participants in this arm will not have access to AI scribe tools and will continue their usual clinical documentation processes
|
|---|---|---|---|
|
Overall Study
STARTED
|
79
|
79
|
80
|
|
Overall Study
COMPLETED
|
79
|
79
|
80
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
A Randomized Controlled Trial of Ambient Artificial Intelligence Scribe Technologies
Baseline characteristics by cohort
| Measure |
Nabla, Vendor of Virtual AI Scribe Technology
n=79 Participants
Participants in this arm will utilize AI scribe tools from Nabla and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The Nabla AI scribe tool is transcriptional and does not provide clinical decision support.
Use Nabla AI Scribe tool provided: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio.
|
Vendor B of Virtual AI Scribe Technology
n=79 Participants
Participants in this arm will utilize AI scribe tools from Vendor B and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The AI scribe tool is transcriptional and does not provide clinical decision support.
Use AI Scribe tool provided by Vendor B: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
|
No Scribe
n=80 Participants
Participants in this arm will not have access to AI scribe tools and will continue their usual clinical documentation processes
|
Total
n=238 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Customized
Age · Between 25 and 34
|
12 Participants
n=2 Participants
|
8 Participants
n=1 Participants
|
17 Participants
n=3 Participants
|
37 Participants
n=24 Participants
|
|
Age, Customized
Age · Between 35 and 44
|
35 Participants
n=2 Participants
|
37 Participants
n=1 Participants
|
39 Participants
n=3 Participants
|
111 Participants
n=24 Participants
|
|
Age, Customized
Age · Between 45 and 54
|
21 Participants
n=2 Participants
|
24 Participants
n=1 Participants
|
14 Participants
n=3 Participants
|
59 Participants
n=24 Participants
|
|
Age, Customized
Age · Between 55 and 64
|
6 Participants
n=2 Participants
|
4 Participants
n=1 Participants
|
7 Participants
n=3 Participants
|
17 Participants
n=24 Participants
|
|
Age, Customized
Age · >=65
|
0 Participants
n=2 Participants
|
3 Participants
n=1 Participants
|
1 Participants
n=3 Participants
|
4 Participants
n=24 Participants
|
|
Age, Customized
Age · Prefer not to answer
|
5 Participants
n=2 Participants
|
3 Participants
n=1 Participants
|
2 Participants
n=3 Participants
|
10 Participants
n=24 Participants
|
|
Sex/Gender, Customized
Sex · Male
|
22 Participants
n=2 Participants
|
31 Participants
n=1 Participants
|
34 Participants
n=3 Participants
|
87 Participants
n=24 Participants
|
|
Sex/Gender, Customized
Sex · Female
|
55 Participants
n=2 Participants
|
45 Participants
n=1 Participants
|
44 Participants
n=3 Participants
|
144 Participants
n=24 Participants
|
|
Sex/Gender, Customized
Sex · Prefer not to answer
|
2 Participants
n=2 Participants
|
3 Participants
n=1 Participants
|
2 Participants
n=3 Participants
|
7 Participants
n=24 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
5 Participants
n=2 Participants
|
7 Participants
n=1 Participants
|
6 Participants
n=3 Participants
|
18 Participants
n=24 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
66 Participants
n=2 Participants
|
68 Participants
n=1 Participants
|
70 Participants
n=3 Participants
|
204 Participants
n=24 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
8 Participants
n=2 Participants
|
4 Participants
n=1 Participants
|
4 Participants
n=3 Participants
|
16 Participants
n=24 Participants
|
|
Race/Ethnicity, Customized
Race · Asian
|
33 Participants
n=2 Participants
|
34 Participants
n=1 Participants
|
31 Participants
n=3 Participants
|
98 Participants
n=24 Participants
|
|
Race/Ethnicity, Customized
Race · Black
|
0 Participants
n=2 Participants
|
2 Participants
n=1 Participants
|
3 Participants
n=3 Participants
|
5 Participants
n=24 Participants
|
|
Race/Ethnicity, Customized
Race · White
|
25 Participants
n=2 Participants
|
31 Participants
n=1 Participants
|
28 Participants
n=3 Participants
|
84 Participants
n=24 Participants
|
|
Race/Ethnicity, Customized
Race · Multiple/Other
|
7 Participants
n=2 Participants
|
6 Participants
n=1 Participants
|
10 Participants
n=3 Participants
|
23 Participants
n=24 Participants
|
|
Race/Ethnicity, Customized
Race · Prefer not to answer
|
14 Participants
n=2 Participants
|
6 Participants
n=1 Participants
|
8 Participants
n=3 Participants
|
28 Participants
n=24 Participants
|
|
Region of Enrollment
United States
|
79 Participants
n=2 Participants
|
79 Participants
n=1 Participants
|
79 Participants
n=3 Participants
|
237 Participants
n=24 Participants
|
|
Specialty
Primary Care
|
37 Participants
n=2 Participants
|
34 Participants
n=1 Participants
|
30 Participants
n=3 Participants
|
101 Participants
n=24 Participants
|
|
Specialty
Medical Specialty
|
33 Participants
n=2 Participants
|
28 Participants
n=1 Participants
|
38 Participants
n=3 Participants
|
99 Participants
n=24 Participants
|
|
Specialty
Surgical Specialty
|
9 Participants
n=2 Participants
|
17 Participants
n=1 Participants
|
12 Participants
n=3 Participants
|
38 Participants
n=24 Participants
|
|
Time-in-note
|
4.78 minutes per note
n=2 Participants
|
4.38 minutes per note
n=1 Participants
|
5.37 minutes per note
n=3 Participants
|
4.58 minutes per note
n=24 Participants
|
|
Single-item burnout
|
3.49 units on a scale
STANDARD_DEVIATION 0.81 • n=2 Participants
|
3.49 units on a scale
STANDARD_DEVIATION 0.77 • n=1 Participants
|
3.50 units on a scale
STANDARD_DEVIATION 0.78 • n=3 Participants
|
3.50 units on a scale
STANDARD_DEVIATION 0.78 • n=24 Participants
|
|
Clinic days per week
|
3.45 days/week
STANDARD_DEVIATION 1.35 • n=2 Participants
|
3.35 days/week
STANDARD_DEVIATION 1.36 • n=1 Participants
|
3.36 days/week
STANDARD_DEVIATION 1.38 • n=3 Participants
|
3.38 days/week
STANDARD_DEVIATION 1.36 • n=24 Participants
|
PRIMARY outcome
Timeframe: Study month 2Population: Providers with this metric logged by Signal in the reporting period.
The primary outcome measure is the change in provider mean time in notes per note in the second month of the trial from the providers baseline mean time in notes per note for the six months prior to enrollment. This change will be computed on the natural log scale. No patient level information will be collected for this outcome measure.
Outcome measures
| Measure |
Nabla, Vendor of Virtual AI Scribe Technology
n=75 Participants
Participants in this arm will utilize AI scribe tools from Nabla and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The Nabla AI scribe tool is transcriptional and does not provide clinical decision support.
Use Nabla AI Scribe tool provided: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio.
|
Vendor B of Virtual AI Scribe Technology
n=77 Participants
Participants in this arm will utilize AI scribe tools from Vendor B and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The AI scribe tool is transcriptional and does not provide clinical decision support.
Use AI Scribe tool provided by Vendor B: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
|
No Scribe
n=78 Participants
Participants in this arm will not have access to AI scribe tools and will continue their usual clinical documentation processes
|
|---|---|---|---|
|
Change in the Time in Notes Per Note
|
-0.85 ln(minutes per note)
Standard Deviation 3.49
|
-0.46 ln(minutes per note)
Standard Deviation 1.16
|
-0.29 ln(minutes per note)
Standard Deviation 1.37
|
SECONDARY outcome
Timeframe: Study month 2Population: Providers who completed the follow-up survey.
The Mini Z 2.0 Survey is a validated 10-item instrument designed to measure key factors influencing workplace satisfaction and burnout among healthcare professionals. Each item is scored on a Likert scale (1-5), with higher scores generally indicating more positive outcomes - greater job satisfaction, sufficiency of time for electronic medical record documentation, and lower levels of stress. For negatively framed items (e.g., stress due to the job or frustration with the electronic medical record), higher scores indicate lower levels of dissatisfaction. The total score ranges from 10 to 50, with scores ≥40 representing a joyful workplace. No patient level information will be collected for this outcome measure.
Outcome measures
| Measure |
Nabla, Vendor of Virtual AI Scribe Technology
n=65 Participants
Participants in this arm will utilize AI scribe tools from Nabla and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The Nabla AI scribe tool is transcriptional and does not provide clinical decision support.
Use Nabla AI Scribe tool provided: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio.
|
Vendor B of Virtual AI Scribe Technology
n=66 Participants
Participants in this arm will utilize AI scribe tools from Vendor B and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The AI scribe tool is transcriptional and does not provide clinical decision support.
Use AI Scribe tool provided by Vendor B: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
|
No Scribe
n=61 Participants
Participants in this arm will not have access to AI scribe tools and will continue their usual clinical documentation processes
|
|---|---|---|---|
|
Provider Burnout Score
|
30.43 score on a scale
Standard Deviation 6.11
|
31.25 score on a scale
Standard Deviation 5.65
|
29.30 score on a scale
Standard Deviation 6.46
|
SECONDARY outcome
Timeframe: Study month 2Population: Providers who completed the follow-up survey.
Provider task load adapted from the NASA Task Load Index (TLX), a validated tool for assessing perceived workload across six sub-scales: mental demand, physical demand, temporal demand, performance, effort, and frustration. For this study, we adapted the TLX to focus on note-writing workload, including four sub-scales (mental demand, temporal demand, physical demand, and effort) as done previously. Each sub-scale is rated from 0 (low task load) to 100 (high task load) and summed together for a total score scale of 0 (low task load) to 400 (high task load), lower is better. No patient level information will be collected for this outcome measure.
Outcome measures
| Measure |
Nabla, Vendor of Virtual AI Scribe Technology
n=65 Participants
Participants in this arm will utilize AI scribe tools from Nabla and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The Nabla AI scribe tool is transcriptional and does not provide clinical decision support.
Use Nabla AI Scribe tool provided: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio.
|
Vendor B of Virtual AI Scribe Technology
n=66 Participants
Participants in this arm will utilize AI scribe tools from Vendor B and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The AI scribe tool is transcriptional and does not provide clinical decision support.
Use AI Scribe tool provided by Vendor B: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
|
No Scribe
n=61 Participants
Participants in this arm will not have access to AI scribe tools and will continue their usual clinical documentation processes
|
|---|---|---|---|
|
Provider Task Load Score
|
56.74 score on a scale
Standard Deviation 24.11
|
50.33 score on a scale
Standard Deviation 22.29
|
60.48 score on a scale
Standard Deviation 20.94
|
SECONDARY outcome
Timeframe: Study month 2Population: Providers who completed the second survey.
The Professional Fulfillment Index (PFI) is a validated 16-item instrument that uses a 5-point Likert scale (0-4) to measure professional fulfillment, work exhaustion, and interpersonal disengagement. For this study, we utilize the 4-item work exhaustion subscale which is a mean of the 4-items within that subscale, where a low score (0) indicates a lower level of exhaustion and a high (4) score indicates greater level of exhaustion. No patient level information will be collected for this outcome measure.
Outcome measures
| Measure |
Nabla, Vendor of Virtual AI Scribe Technology
n=65 Participants
Participants in this arm will utilize AI scribe tools from Nabla and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The Nabla AI scribe tool is transcriptional and does not provide clinical decision support.
Use Nabla AI Scribe tool provided: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio.
|
Vendor B of Virtual AI Scribe Technology
n=66 Participants
Participants in this arm will utilize AI scribe tools from Vendor B and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The AI scribe tool is transcriptional and does not provide clinical decision support.
Use AI Scribe tool provided by Vendor B: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
|
No Scribe
n=61 Participants
Participants in this arm will not have access to AI scribe tools and will continue their usual clinical documentation processes
|
|---|---|---|---|
|
Provider Professional Fulfillment
|
1.67 score on a scale
Standard Deviation 0.90
|
1.51 score on a scale
Standard Deviation 0.77
|
1.82 score on a scale
Standard Deviation 0.80
|
SECONDARY outcome
Timeframe: Study month 2Population: Scribe-assigned providers who completed the posttrial survey.
Self-reported satisfaction survey that asks physicians to consider note accuracy, patient safety, equity, and other potential unintended consequences and rate their overall likelihood to recommend use of the tool on a 1-10 scale. Higher scores (10) indicate greater satisfaction and likelihood to recommend, whereas lower scores (1) indicate dissatisfaction and unlikelihood to recommend. Providers are grouped as "Promoters" if they respond 9-10, "Passive" if they respond 7-8, and "Detractors" if they respond with a value less than or equal to 6. This grouping matches commonly accepted "Net Promoter Score" groupings. No patient level information will be collected for this outcome measure.
Outcome measures
| Measure |
Nabla, Vendor of Virtual AI Scribe Technology
n=65 Participants
Participants in this arm will utilize AI scribe tools from Nabla and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The Nabla AI scribe tool is transcriptional and does not provide clinical decision support.
Use Nabla AI Scribe tool provided: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio.
|
Vendor B of Virtual AI Scribe Technology
n=66 Participants
Participants in this arm will utilize AI scribe tools from Vendor B and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The AI scribe tool is transcriptional and does not provide clinical decision support.
Use AI Scribe tool provided by Vendor B: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
|
No Scribe
Participants in this arm will not have access to AI scribe tools and will continue their usual clinical documentation processes
|
|---|---|---|---|
|
Number of Physicians Who Are Considered Detractors, Passive, or Promoters
Detractor (<=6)
|
25 Participants
|
21 Participants
|
—
|
|
Number of Physicians Who Are Considered Detractors, Passive, or Promoters
Passive (7-8)
|
17 Participants
|
15 Participants
|
—
|
|
Number of Physicians Who Are Considered Detractors, Passive, or Promoters
Promoter (9-10)
|
23 Participants
|
30 Participants
|
—
|
SECONDARY outcome
Timeframe: Study month 2The study team will use physician-level billing information via RVU to determine their change in productivity from a retrospective baseline 6 months prior to enrollment. No patient level information will be collected for this outcome measure.
Outcome measures
| Measure |
Nabla, Vendor of Virtual AI Scribe Technology
n=79 Participants
Participants in this arm will utilize AI scribe tools from Nabla and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The Nabla AI scribe tool is transcriptional and does not provide clinical decision support.
Use Nabla AI Scribe tool provided: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio.
|
Vendor B of Virtual AI Scribe Technology
n=79 Participants
Participants in this arm will utilize AI scribe tools from Vendor B and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The AI scribe tool is transcriptional and does not provide clinical decision support.
Use AI Scribe tool provided by Vendor B: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
|
No Scribe
n=80 Participants
Participants in this arm will not have access to AI scribe tools and will continue their usual clinical documentation processes
|
|---|---|---|---|
|
Change in Provider RVU
|
-58.66 monthly work RVU
Standard Deviation 132.93
|
-13.89 monthly work RVU
Standard Deviation 151.30
|
-30.69 monthly work RVU
Standard Deviation 155.98
|
SECONDARY outcome
Timeframe: Study month 2Population: Providers with reported data for this metric in Signal. To be included, a provider needs at least 5 appointments scheduled per week within the reporting period with Pajama Time.
We will examine change from a retrospective baseline 6 months prior to enrollment in Signal metrics including pajama time per scheduled day. Using this data will determine how a providers time is utilized in the EHR. No patient level information will be collected for this outcome measure.
Outcome measures
| Measure |
Nabla, Vendor of Virtual AI Scribe Technology
n=55 Participants
Participants in this arm will utilize AI scribe tools from Nabla and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The Nabla AI scribe tool is transcriptional and does not provide clinical decision support.
Use Nabla AI Scribe tool provided: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio.
|
Vendor B of Virtual AI Scribe Technology
n=46 Participants
Participants in this arm will utilize AI scribe tools from Vendor B and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The AI scribe tool is transcriptional and does not provide clinical decision support.
Use AI Scribe tool provided by Vendor B: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
|
No Scribe
n=46 Participants
Participants in this arm will not have access to AI scribe tools and will continue their usual clinical documentation processes
|
|---|---|---|---|
|
Change in EHR Signal (Activity) Data - Pajama Time
|
1.62 minutes/day
Standard Deviation 24.92
|
0.33 minutes/day
Standard Deviation 29.24
|
-3.71 minutes/day
Standard Deviation 19.63
|
SECONDARY outcome
Timeframe: Study month 2Population: Providers with reported data in this Signal metric. To be included, a provider needs at least 5 appointments scheduled per week within the reporting period.
We will examine change from a retrospective baseline 6 months prior to enrollment in Signal metrics including time outside scheduled hours per scheduled day. Using this data will determine how a providers time is utilized in the EHR. No patient level information will be collected for this outcome measure.
Outcome measures
| Measure |
Nabla, Vendor of Virtual AI Scribe Technology
n=76 Participants
Participants in this arm will utilize AI scribe tools from Nabla and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The Nabla AI scribe tool is transcriptional and does not provide clinical decision support.
Use Nabla AI Scribe tool provided: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio.
|
Vendor B of Virtual AI Scribe Technology
n=77 Participants
Participants in this arm will utilize AI scribe tools from Vendor B and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The AI scribe tool is transcriptional and does not provide clinical decision support.
Use AI Scribe tool provided by Vendor B: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
|
No Scribe
n=78 Participants
Participants in this arm will not have access to AI scribe tools and will continue their usual clinical documentation processes
|
|---|---|---|---|
|
Change in EHR Signal (Activity) Data - Time Outside Scheduled Hours
|
-5.31 minutes/day
Standard Deviation 16.84
|
-1.70 minutes/day
Standard Deviation 11.42
|
-1.43 minutes/day
Standard Deviation 12.36
|
SECONDARY outcome
Timeframe: Study month 2Population: Providers for whom this record was reported by Signal. To be included, a provider needs at least 5 appointments scheduled per week within the reporting period.
We will examine change from a retrospective baseline 6 months prior to enrollment in Signal metrics including time spent in the system on unscheduled days where . Using this data will determine how a providers time is utilized in the EHR. No patient level information will be collected for this outcome measure.
Outcome measures
| Measure |
Nabla, Vendor of Virtual AI Scribe Technology
n=65 Participants
Participants in this arm will utilize AI scribe tools from Nabla and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The Nabla AI scribe tool is transcriptional and does not provide clinical decision support.
Use Nabla AI Scribe tool provided: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio.
|
Vendor B of Virtual AI Scribe Technology
n=73 Participants
Participants in this arm will utilize AI scribe tools from Vendor B and will continue their usual clinical documentation processes, supported by the scribe software, which integrates with the EHR and automatically adds the generated text to the note. The AI scribe tool is transcriptional and does not provide clinical decision support.
Use AI Scribe tool provided by Vendor B: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
|
No Scribe
n=73 Participants
Participants in this arm will not have access to AI scribe tools and will continue their usual clinical documentation processes
|
|---|---|---|---|
|
Change in EHR Signal (Activity) Data - Time on Unscheduled Days
|
-6.63 minutes/day
Standard Deviation 23.89
|
1.51 minutes/day
Standard Deviation 26.12
|
-3.38 minutes/day
Standard Deviation 19.61
|
Adverse Events
Nabla, Vendor of Virtual AI Scribe Technology
Vendor B of Virtual AI Scribe Technology
No Scribe
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. John N. Mafi, MD, MPH
University of California, Los Angeles
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place